Optimi Health Corp.’s Lock-Up Period Will Expire Tomorrow (NASDAQ:OPTH)

Optimi Health’s (NASDAQ:OPTH – Get Free Report) lock-up period is set to expire on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its initial public offering on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. After the expiration of Optimi Health’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Analysts Set New Price Targets

OPTH has been the topic of a number of research analyst reports. Weiss Ratings raised shares of Optimi Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 27th. Wall Street Zen raised shares of Optimi Health to a “hold” rating in a report on Saturday, July 25th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce”.

Get Our Latest Research Report on Optimi Health

Optimi Health Trading Up 3.2%

Shares of Optimi Health stock opened at $2.25 on Friday. The stock has a market cap of $12.89 million and a price-to-earnings ratio of -2.96. Optimi Health has a twelve month low of $1.90 and a twelve month high of $6.40. The company has a 50-day moving average of $3.73. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.06 and a quick ratio of 0.03.

Optimi Health Company Profile

(Get Free Report)

Optimi Health Corp. is a Canadian pharmaceutical company focused on developing and manufacturing psychedelic compounds for medical use. Its products include psilocybin produced from mushrooms and MDMA manufactured to pharmaceutical quality standards at its facilities in British Columbia. The company’s psychedelic products are intended for clinical research and regulated medical use, including access programs where permitted. Optimi has also shipped products to Australia, where certain psychedelic-assisted treatments may be prescribed by authorized clinicians under national regulations.

Read More

Receive News & Ratings for Optimi Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Optimi Health and related companies with MarketBeat.com's FREE daily email newsletter.